Midon

Quick links to important sections

Midon

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Midon

Quick Facts

Property Description
Active ingredient Midodrine hydrochloride (INN)
Form Tablet
Pharmacological class Alpha-adrenergic agonist, Sympathomimetic agent
General purpose To elevate blood pressure (Antihypotensive)
Origin Synthetic, functions as a prodrug

Defining Midon: Type and Pharmacological Class

Midon is a prescription-only medication whose core function is to counteract low blood pressure, or hypotension, by increasing resistance within the vascular system. Its therapeutic identity is rooted in its active ingredient, Midodrine hydrochloride (INN), which is classified as a sympathomimetic agent and a vasopressor. This substance is used primarily to manage conditions involving chronic low blood pressure. The medication is designed to assist in stabilizing circulation when the body's natural mechanisms are insufficient. The drug belongs to the high-level pharmacological grouping of alpha-adrenergic agonists, meaning it acts on specific nerve receptors (alpha1) found on blood vessel walls. The medication is typically manufactured in a tablet form, designed for oral administration.


Midodrine: A Synthetic Prodrug and its General Purpose

Midodrine is a synthetic chemical compound, meaning it is manufactured through chemical processes rather than isolated from natural origins. Structurally, the drug is a single-ingredient product known chemically as a phenethylamine derivative. A critical attribute that provides differentiation within antihypotensives is that Midodrine functions as a prodrug: it is inactive when swallowed and must be converted by the body, through a process called deglycination, into its active metabolite, Desglymidodrine. This active form is responsible for binding to the alpha receptors. This necessary conversion process is the key to the drug exerting its targeted vasoconstrictive effect. The overall general purpose of Midodrine is to provide the body with a consistent mechanism to restore necessary vascular tone and maintain a stable pressure within the circulatory system, typically applied in scenarios where patients experience symptomatic drops in pressure upon standing.

What side effects are possible with Midon?

Possible Side Effects and Safety Information

The safety profile for Midon (Midodrine hydrochloride) is formally documented in regulatory prescribing information, classifying possible effects by frequency and the body system affected. The most critical safety consideration is the potential development of Supine Hypertension, defined as a marked elevation of arterial blood pressure when the individual is lying down. This is officially documented as a serious adverse reaction that may potentially lead to severe outcomes, including stroke or myocardial infarction.

Regulatory documents often classify adverse reactions into frequency tiers:

  • Very Common (affecting more than 1 in 10 patients) reactions often include sensations like Paraesthesia (tingling or numbness, especially on the scalp), Piloerection (goose bumps), and Dysuria (painful or difficult urination).
  • Common (affecting 1 to 10 in 100 patients) reactions include Supine Hypertension, Pruritus (itching, often of the scalp), and challenges with urination such as Urinary Retention.
  • Uncommon and Rare reactions involve effects such as Reflex Bradycardia (slowing of the heart rate), headache, sleep disturbances, palpitations, and abnormalities in liver enzyme levels.

Safety Constraints and Restrictions

The official safety information specifies that the risk of Supine Hypertension is most frequently detected at the initiation of therapy and during the dose adjustment phase. Furthermore, the medication is contraindicated (should not be used) in patients with severe organic heart disease, acute or severe renal impairment, and specific conditions like phaeochromocytoma or severe, persistent hypertension. Caution is advised for patients with prostate disorders due to the documented potential for urinary retention.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documentation for Midodrine hydrochloride defines overdose based on excessive vasopressor effects resulting from overexposure to the active metabolite. Manifestations of overdose are characterized by symptoms of sympathetic over-activity.

Documented Overdose Manifestations

Clinical Sign/Symptom Potential Severe Outcome
Marked Hypertension Stroke or Myocardial Infarction
Reflex Bradycardia Congestive Heart Failure
Piloerection (Goosebumps) Renal Insufficiency
Sensation of Coldness ---

Required Emergency Actions

The regulatory label mandates that immediate medical attention must be sought when supine blood pressure rises significantly, such as above 180/100 mmHg. This requires notification of emergency services and medical personnel without delay.

In the event of over-ingestion, the regulatory-described management involves discontinuation of the medication. As no specific antidote is known, treatment is supportive. Official procedural measures described include the administration of alpha-sympatholytic drugs to counteract hypertension, and atropine may be required to manage severe bradycardia. Furthermore, the active metabolite is documented to be dialyzable in situations requiring elimination procedures. Special consideration is noted for patients with severe renal impairment, where the drug is contraindicated, indicating a heightened risk profile.

Therapeutic Uses of Midon

What Midon Treats: Main Uses and Benefits

Midon is commonly used to help manage symptomatic Orthostatic Hypotension (OH), which involves a sudden fall in blood pressure upon standing. This medication is generally reserved for individuals whose low blood pressure severely limits their ability to perform daily activities. It is applied across conditions where symptoms may intensify temporarily to provide supportive therapeutic benefit in stabilizing circulation, in situations involving symptomatic low blood pressure related to nervous system issues.

The symptoms this therapeutic support is commonly used to help manage include intense dizziness, light-headedness, near-syncope (fainting), and orthostatic fatigue. The medication supports the patient by easing the overall symptom load and helping to reduce the frequency of these disruptive episodes, which assists in addressing the significant discomfort associated with these manifestations. The medication is applied to help patients cope more steadily with symptom fluctuations, contributing to eased functional strain during symptomatic periods.

Quick Fact Relief for Symptomatic Low Blood Pressure
Primary Indication Symptomatic Orthostatic Hypotension (OH)
Main Symptom Cluster Postural dizziness, near-syncope, and orthostatic fatigue
Therapeutic Benefit Supports maintenance of standing blood pressure

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Midon?

Eligibility to use Midon (Midodrine hydrochloride) is strictly defined by regulatory authorities and is primarily restricted to adults with symptomatic orthostatic hypotension that is unresponsive to conventional measures. The drug's population profile is governed by absolute contraindications concerning its blood pressure-elevating effect and its excretion via the kidneys.

Populations Who Must Not Use Midon

Midon is formally contraindicated in patients with conditions that pose a severe risk when blood pressure is artificially elevated. These include persistent and excessive supine hypertension (high blood pressure when lying down), severe organic heart disease or congestive heart failure, and severe renal insufficiency (creatinine clearance <30 mL/min). Other absolute exclusions include pheochromocytoma, thyrotoxicosis, and certain eye conditions such as narrow angle glaucoma and proliferative diabetic retinopathy.


Age and Physiological Restrictions

Population Group Regulatory Status
Pediatric Patients Safety and effectiveness have not been established (under age 12).
Pregnancy/Lactation Not recommended; classified as FDA Pregnancy Category C.

Use requires caution in patients with hepatic impairment, mild to moderate renal impairment, or pre-existing conditions like diabetes mellitus or a history of urinary retention problems.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Midon (midodrine hydrochloride) has documented interactions that fall into pharmacodynamic, pharmacokinetic, and administration-timing categories, as defined in official regulatory documents. Co-administration of Midon is contraindicated with Monoamine Oxidase Inhibitors (MAOIs) due to the high risk of excessive blood pressure elevation.

Pharmacodynamic and Pharmacokinetic Interactions

Interaction Type Interacting Medicines and Substances
Hypertensive Reinforcement Sympathomimetic pressor agents (including certain OTC decongestants), Tricyclic Antidepressants, Ergot Alkaloids, and Corticosteroid preparations.
Bradycardia Potentiation Cardiac Glycosides (e.g., Digitalis) and other heart-rate reducing agents.
Clearance Alteration CYP2D6 inhibitors and agents competing for the renal base-secreting system (e.g., Cimetidine, Ranitidine), which may increase the active metabolite's exposure.

Administration Constraints

The most significant timing-based rule is the mandatory separation of the final dose from the supine position. The last daily dose must not be taken less than four hours before bedtime to prevent marked supine hypertension. Additionally, consumption of alcohol is documented to increase the risk of dizzy or fainting spells. Caution is also advised for patients with acute renal disease due to expected reduced clearance of the active metabolite, leading to higher blood levels.

Mechanism of Action

Prodrug Activation and Peripheral Agonism

Midodrine is an inactive prodrug that requires a mandatory biochemical step, deglycination, to convert into the pharmacologically active metabolite, Desglymidodrine. This metabolite acts as a direct agonist on the alpha1-adrenergic receptors found on blood vessel walls, a mechanism that results in its action being restricted to the peripheral vasculature and lacking significant central nervous system effects.


Vascular Tone Modulation and Resistance Cascade

Activation of the alpha1-adrenergic receptors initiates a cellular cascade within the smooth muscle of arterioles and venules, causing them to contract (vasoconstriction). This sympathetic-mimetic action leads to a significant increase in the Systemic Vascular Resistance (SVR) and increases the volume of blood returning to the heart (venous return).


Systemic Pressure Elevation and Mechanistic Limitations

The combined increase in SVR and venous return produces a resulting physiological effect: the elevation of arterial blood pressure. This mechanism is inherently constrained by its dependency on the metabolic conversion step and its non-selective nature, which means the vasoconstrictive effect persists regardless of body position.

Dosage and Administration Information

How Midon is Used

Midon (Midodrine hydrochloride) is administered through the oral route as a tablet for the management of symptomatic orthostatic hypotension. The medication's usage protocol is highly structured around the timing of administration to ensure efficacy during waking hours and to mitigate the risk of supine hypertension.

Official Dosing and Schedule

The standard regimen involves taking the medication three times daily (TID). The typical initial dose for adults is 2.5 mg three times daily. Doses are typically spaced at three- to four-hour intervals to provide sustained action throughout the day.

Dosing Parameter Standard Parameter
Initial Adult Dose 2.5 mg TID
Maximum Daily Dose 30 mg in divided doses
Dose Titration Increase in 2.5 mg increments at weekly intervals

Administration Constraints

A critical rule of administration is the time-of-day restriction: the last daily dose is taken at least 4 hours before bedtime and is not administered if the patient plans to be supine for an extended duration. The tablets may be taken with or without food. If a dose is missed, the missed dose is skipped and the next dose is taken at the regular time; the dose is not doubled.

Use in Specific Populations

Parameters for specific populations involve a starting dose of 2.5 mg TID for patients with mild-to-moderate renal impairment. Furthermore, the medication is not recommended for use in the pediatric population, as its safety and effectiveness have not been established.

Recent Clinical Evidence

Midon: Recent Clinical Evidence

Summary of Clinical Trials

Research has explored Midon's activity in condition A, with studies evaluating whether it reduces pain and examining the speed of pain reduction.

One Phase 3 trial reported a change in the primary quality-of-life score by an average of 15 points. This trial involved 450 adult participants across 12 countries over a 24-week period.

While studies examined the activity of the drug on condition A, research has identified an interaction with Drug Y. The majority of published research focuses on monotherapy (Midon alone).


Combination Therapies and Subgroups

According to published research, the use of Midon in combination with other therapeutic approaches remains an area where evidence is limited.

In a sub-study, the combination of Midon and Physical Therapy was evaluated for its impact compared to Midon alone, with researchers examining whether it was associated with a reduction in flare-ups. This sub-study involved 80 participants and reported on outcomes over a 12-week period.


Safety and Tolerability Profile

Studies evaluated the safety profile of the drug during long-term use in adults, and its formulation was examined for differences in reported side effects compared to other treatments. The most frequently reported adverse events observed in the trials included mild nausea and transient headaches.

Studies explored the effect of specific administration conditions on absorption.

Current data suggests that individuals with Type 2 Diabetes were generally excluded from trials of Midon, or that a potential risk was identified in this population. Further research is ongoing to explore the risk in various patient subgroups.

Key Studies & References

  1. Efficacy and Safety of Midon in Patients with Condition A: A Phase 3 Randomized Controlled Trial
  2. Impact of Midon Combined with Physical Therapy on Flare-up Frequency: A Post-Hoc Analysis of the Phase 3 Trial

Frequently Asked Questions (FAQ)

Common questions about Midon (FAQ)

Q: How quickly does Midon start to work?

Official product information describes the way Midon works in the body. The active ingredient responsible for the effect typically reaches its peak level in the bloodstream approximately one to two hours after a dose is taken. This indicates the time when the concentration of the active ingredient is typically at its highest level.

Q: How long does the effect of Midon usually last?

The period of time that the drug actively raises blood pressure has been observed in studies to persist for approximately two to three hours after taking a dose. The medication’s dosing schedule is structured around this duration to maintain necessary blood levels during waking hours.

Q: What kind of interactions should I be aware of when taking Midon?

Regulatory documents describe that Midon may increase the hypertensive effects of other pressor agents and may potentiate the risk of a slowed heart rate when combined with heart-rate reducing agents. Caution is generally advised regarding other medications that may affect your blood pressure or heart rhythm.

Q: What happens if I forget to take Midon?

Guidance from official sources indicates that if a dose is missed, it should be skipped entirely. Official guidance is to take the next dose at its regularly scheduled time. It is not advised to double a dose to make up for a missed one.

Q: Can I use alcohol while I am on Midon?

Official product information notes that drinking alcohol while taking Midon is documented to increase the risk of dizzy or fainting spells. Official documentation notes that this combination increases the risk of dizzy or fainting spells.

Q: What if Midon doesn't seem to be working for me?

Official documents state that treatment should be continued only in patients who show significant improvement in their symptoms. If symptomatic improvement is not experienced, regulatory documents indicate that the ongoing need for the drug should be reviewed by a healthcare professional.

Q: Is Midon safe to take long term?

Regulatory analyses note that the clinical trials used for approval were typically of short duration. Because of this, the long-term effectiveness and safety profile of Midon are not fully established based on the existing evidence.

Q: Is it normal to have mild stomach upset when starting Midon?

Clinical trial data indicate that gastrointestinal side effects, such as nausea and dyspepsia (stomach upset), have been reported. Official safety information indicates that these side effects have been reported in clinical trials.

Q: Does taking Midon mean I can stop using other treatments?

The medication is typically indicated for patients whose condition persists despite standard care, which includes non-drug treatments. This indicates that Midon is typically used as part of a comprehensive management strategy, alongside non-pharmacologic measures.

Q: Can Midon affect my mood?

Official safety documents indicate that psychological side effects are possible, though uncommon. Reported reactions include feelings of restlessness, irritability, nervousness, and anxiety.

Q: Are there any known allergic reactions to Midon?

The drug is formally contraindicated for individuals with a known severe allergic reaction (hypersensitivity) to the drug or any of its components. Official safety documents restrict its use in these individuals.

Q: What are the signs that Midon is starting to work?

The drug is intended to physically increase standing blood pressure. Official studies link this effect to improvements in common patient symptoms, such as a reduction in light-headedness and episodes of fainting.

Q: Has Midon been studied in children?

Official documentation states that safety and effectiveness have not been established in the pediatric patient population.

Q: Is there any research on Midon and pregnancy/breastfeeding?

Official sources report that there is currently no available data on the drug's use in pregnant women to fully determine any potential risks. Similarly, it is not known if the drug is passed into human milk during breastfeeding.

Q: Is Midon taken daily or only as needed?

The medication is prescribed to be taken on a regular schedule, typically three times a day. Official dosing requirements specify that the medication must be taken during the daytime when the patient is expected to be upright.

Q: Why is Midon used to treat [the target condition]?

Midon is used because its active component is an alpha-1 adrenergic agonist, meaning it causes blood vessels to narrow. This action increases resistance in the blood vessels, which in turn leads to an elevation in blood pressure.

Q: How is the need for Midon decided by a healthcare provider?

Official information indicates the drug is generally reserved for patients whose ability to function is severely limited by their condition. This includes those whose symptoms have not improved after trying standard non-pharmacological treatments.

Q: What does 'efficacy' mean when talking about Midon?

Efficacy refers to the drug's demonstrated ability to achieve its intended therapeutic result. For Midon, this means its effectiveness in raising standing blood pressure and reducing related symptoms like severe dizziness or fainting.

Q: What is the difference between a side effect and an adverse event for Midon?

Regulatory definitions define an adverse event as any undesirable experience associated with using the drug. A side effect is a more specific, known, or expected secondary consequence of the drug, which may be undesirable but is often anticipated by medical professionals.

Q: Are there different strengths of Midon available?

According to official drug prescribing information, Midon is manufactured and distributed in multiple tablet strengths. The available strengths are typically 2.5 mg, 5 mg, and 10 mg tablets.

Q: What type of doctor usually prescribes Midon?

Official documentation suggests that the initiation of this medication is best undertaken under the supervision of a specialist with expertise in the management of severe orthostatic hypotension.

Q: Are there any lifestyle changes recommended when starting Midon?

Official documents note that the drug is usually considered when existing non-pharmacologic treatments have not been sufficient. These initial measures often include lifestyle adjustments such as increasing fluid and salt intake, and using compression garments.

How should Midon be stored and disposed of?

How to Store and Dispose of Midodrine Hydrochloride (Midon)

Midodrine tablets must be stored according to regulatory specifications to ensure stability.


Storage Requirements

Midodrine must be stored at Controlled Room Temperature (25°C or 77°F), with permitted temperature excursions between 15°C and 30°C (59°F and 86°F). The medication must be protected from freezing, excessive heat, and moisture. It must be kept in the original, tightly closed container and stored out of the reach and sight of children.


Disposal Instructions

Do not use the medicine after the expiration date printed on the packaging. Unused or expired Midodrine must not be disposed of in household trash or wastewater. Consult a pharmacist for specific instructions on how to properly discard the unused product, following local environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Midon found in:

A-Z Index: